Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (549)	3/5/2004 1:17:53 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

VTIV Had a good upgap this morning after it reported earnings yesterday.<g> bigcharts.marketwatch.com Ventiv Health, Inc. Reports Financial Results For Fourth Quarter and Full Year 2003 Thursday March 4, 4:15 pm ET * Quarterly revenues up 51% to $75.3 million * Quarterly earnings per share from continuing operations up 186% from $0.07 to $0.20, driven by operating leverage on higher revenues * Deployment completed of 200-rep sales force expansion for Bayer * 2004 new business wins to-date totaling 365 reps with 10 clients, including Synthon * Year-end cash balance of $57 million; $11.8 million cash from operations for full year SOMERSET, N.J., March 4 /PRNewswire-FirstCall/ -- Ventiv Health, Inc. (Nasdaq: VTIV - News), a leading provider of comprehensive marketing and sales solutions to the pharmaceutical and life sciences industries, today announced financial results for the fourth quarter and full year of 2003. Results discussed below exclude Ventiv's discontinued Communications and European Contract Sales businesses and a gain on the sale of real estate in Ventiv's Sales & Marketing business. Quarterly Results: Total revenues for the fourth quarter of 2003 were $75.3 million,compared to $49.9 million for the fourth quarter of 2002. Earnings from continuing operations before income taxes were $7.9 million, compared to $2.5 million for the fourth quarter of 2002. Net earnings from continuing operations were $5.0 million, compared to $1.5 million for the fourth quarter of 2002. Diluted earnings per share from continuing operations were $0.20,compared to $0.07 for the fourth quarter of 2002. Full-Year Results: Total revenues for 2003 were $224.5 million, compared to $215.4 million for 2002. Earnings from continuing operations before tax were $15.4 million,compared to $8.0 million for 2002. Net earnings from continuing operations were $9.6 million, compared to $4.9 million for 2002. Diluted earnings per share from continuing operations were $0.41,compared to $0.22 for 2002. Snip Cash generation: Ventiv generated $11.8 million of cash from operations during the year, ending the year with $57 million of cash and no debt. To see the full report: biz.yahoo.com